Optimizing HDMTX Outcomes:
DME & Toxicity Management
A focused scientific webinar discussing High-Dose Methotrexate clinical principles, DME differentiation, toxicity risks, and practical management pathways.
Agenda
Introduction & Welcoming
Dr. Abdulaziz Hamadah
Moderator: Dr. Fatima Khadadah
HDMTX Clinical Principles
Dr. Salem Alshemmari
Differentiating DME from Toxicity, Diagnosis and Risk assessment of DME
Dr. Ahmad Alhuraiji
Moderator: Dr. Muath Al Nassar
Emergency Management vs Best Supportive Care: Decision-Making Frameworks
Dr. Nisreen Khalifah
MENA Guidelines Alignment: Practical Recommendations for HDMTX and DME outcomes
Joint: Dr. Ahmad Alhuraiji & Dr. Nisreen Khalifah
Challenging Case Presentation
Dr. Nisreen Khalifah
Q&A
All Faculty
Closing Remarks
Dr. Abdulaziz Hamadah
Speakers
Chairperson
Dr. Abdulaziz Hamadah
Consultant Hematologist And Head Of Hematology Department At Kuwait Cancer Control Center
Speaker
Dr. Salem Alshemmari
Professor, Department of Medicine College of Medicine Kuwait University (KU) Consultant Department of Haemato-Oncology
Speaker
Dr. Ahmad Alhuraiji
Hemato-Oncologist Consultant Working In The Department Of Hematology At Kuwait Cancer Control Centre
Speaker
Dr. Nisreen Khalifah
Consultant Pediatric Oncologist in the Solid Tumor Unit at the NBK Children’s Hospital in Kuwait
Moderators
Moderator
Dr. Fatima Khadadah
FRCPC and ABIM in Internal Medicine and Hematology
Moderator
Dr. Muath Al Nassar
Consultant In Medical Oncology (Thoracic , Head & Neck And Sarcoma Unit )At Kuwait Cancer Control Center
Registration
Sponsored by
